We are live on ! Find out more
LA

Lee Ainslie Maverick Capital

AUM $11.3B
1-Year Est. Return 76.6%
 

Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.

This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+76.6%
3 Year Est. Return
+266.43%
5 Year Est. Return
+219.63%
10 Year Est. Return
+601.38%
AUM
$6.38B
AUM Growth
-$459M
Cap. Flow
-$820M
Cap. Flow %
-12.85%
Top 10 Hldgs %
45.86%
Holding
58
New
12
Increased
8
Reduced
22
Closed
13

Sector Composition

Rank Sector Weight
1 Healthcare 20.18%
2 Technology 18.88%
3 Communication Services 15%
4 Financials 10.26%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHS icon
26
Universal Health Services
UHS
$10.4B
$92.9M 1.46%
+834,757
New +$87.7M
AVGO icon
27
Broadcom
AVGO
$1.75T
$92.9M 1.46%
+9,232,500
New +$82.5M
MTG icon
28
MGIC Investment
MTG
$6.34B
$91.7M 1.44%
9,840,768
-2,063,788
-17% -$18.1M
TMH
29
DELISTED
Team Health Holdings Inc
TMH
$90.3M 1.42%
+1,570,042
New +$90.5M
PTC icon
30
PTC
PTC
$16.8B
$87M 1.36%
2,374,064
+469,808
+25% +$17.4M
ZU
31
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
$79.5M 1.25%
+3,399,491
New +$104M
NRF
32
DELISTED
NorthStar Realty Finance Corp.
NRF
$67.6M 1.06%
1,924,001
+622,095
+48% +$22.2M
JD icon
33
JD.com
JD
$39.7B
$61.7M 0.97%
+2,668,114
New +$65.7M
QLIK
34
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$57M 0.89%
1,843,788
-724,990
-28% -$20.7M
PACB icon
35
Pacific Biosciences
PACB
$420M
$50.6M 0.79%
6,459,784
CYH icon
36
Community Health Systems
CYH
$424M
$50M 0.78%
1,121,758
-1,441,126
-56% -$61.6M
LBTYA icon
37
Liberty Global Class A
LBTYA
$3.63B
$48.3M 0.76%
1,165,992
-1,178,109
-50% -$45.2M
NVS icon
38
Novartis
NVS
$302B
$48.1M 0.75%
579,616
+275,428
+91% +$22.8M
APTV icon
39
Aptiv
APTV
$10B
$46.8M 0.73%
+644,043
New +$44.4M
BUD icon
40
AB InBev
BUD
$155B
$40.1M 0.63%
356,954
-577,463
-62% -$64M
CXP
41
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$38.3M 0.6%
1,511,277
-2,722,988
-64% -$68.5M
QSR icon
42
Restaurant Brands International
QSR
$28.2B
$37.4M 0.59%
+957,261
New +$36.8M
ICE icon
43
Intercontinental Exchange
ICE
$90.5B
$29.7M 0.47%
677,815
-90,000
-12% -$3.86M
BABA icon
44
Alibaba
BABA
$286B
$26M 0.41%
250,000
-1,950,000
-89% -$200M
CSLT
45
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$13.4M 0.21%
1,144,324
ABBV icon
46
AbbVie
ABBV
$468B
-4,723,578
Closed -$273M
AMCX icon
47
AMC Global Media
AMCX
$511M
-973,456
Closed -$56.9M
ASH icon
48
Ashland
ASH
$3.33B
-2,247,670
Closed -$114M
BIDU icon
49
Baidu
BIDU
$31.6B
-113,630
Closed -$24.8M
CTSH icon
50
Cognizant
CTSH
$27.9B
-3,375,000
Closed -$151M

Similar funds

Lee Ainslie's Q4 2014 Portfolio in Review

As of Q4 2014, Lee Ainslie held 58 positions worth $6.38B, down 6.7% from $6.84B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lee Ainslie withdrew a net $820M in Q4 2014, closing 13 positions and reducing 22 holdings. Its most notable exit was AbbVie, an estimated $273M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Lee Ainslie opened a new position in Alphabet (Google) Class C worth $347M.

  • Lee Ainslie's largest Q4 2014 buy was Alphabet (Google) Class C: 13,220,939 shares worth $347M.
  • Lee Ainslie added most to Vulcan Materials in Q4 2014, an estimated $138M increase.
  • Lee Ainslie's biggest Q4 2014 reduction was Alibaba, cutting an estimated $200M.
  • Lee Ainslie fully exited AbbVie in Q4 2014, selling an estimated $273M.
  • Lee Ainslie's ten largest holdings make up 46% of its $6.38B portfolio in Q4 2014.
  • Lee Ainslie opened 12 new positions and closed 13 in Q4 2014.
  • Lee Ainslie's portfolio value fell 6.7% quarter-over-quarter to $6.38B.

Based on Maverick Capital's 13F filing for Q4 2014, filed 17 Feb 2015.